Help

BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.

To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.

To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.

Login Register Subscribe

Bayer must pay $2B to couple in Roundup cancer trial

Reprints
Bayer

(Reuters) — A California jury on Monday awarded more than $2 billion to a couple who claimed Bayer AG's glyphosate-based Roundup weed killer caused their cancer, marking the third consecutive U.S. jury verdict against the company in litigation over the chemical.

The jury in San Francisco Superior Court in Oakland said the company was liable for plaintiffs Alva and Alberta Pilliod's contracting non-Hodgkin's lymphoma, a spokeswoman for the couple said.

It awarded $18 million in compensatory and $1 billion in punitive damages to Alva Pilliod and $37 million in compensatory and $1 billion in punitive damages to his wife, Alberta Pilliod.

The jury found Roundup had been defectively designed, that the company failed to warn of the herbicide's cancer risk and that the company acted negligently.

Bayer, which bought Roundup-maker Monsanto last year for $63 billion, faces more than 13,400 U.S. lawsuits over the herbicide's alleged cancer risk.

Bayer denies the allegations, saying decades of studies by the company and independent scientists have shown glyphosate and Roundup to be safe for human use. Bayer also points to several regulators around the world that found glyphosate not carcinogenic to humans.

 

Read Next

  • Jury rules against Bayer in Roundup cancer case

    (Reuters) — A U.S. jury on Tuesday found Bayer AG's glyphosate-based weed killer to be a "substantial factor" in causing a man's non-Hodgkin's lymphoma, allowing the trial to proceed into a second phase on liability and damages.